Felsenstein K M, Lewis-Higgins L
CNS-Department of Biophysics and Molecular Biology, Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, CT 06492.
Neurosci Lett. 1993 Apr 2;152(1-2):185-9. doi: 10.1016/0304-3940(93)90514-l.
Mutations within the beta-amyloid precursor protein (beta-APP) gene that cosegregate with early onset familial Alzheimer's disease (FAD) and hereditary cerebral hemorrhage with amyloidosis of the Dutch-type (HCHWA-D) have been reported. The effects of these mutations on the products of both the non-amyloidogenic and potentially amyloidogenic processing pathways of the beta-APP protein were examined in stably transfected cells. Processing of these mutants appeared to be the same as wild-type. These results contrasted sharply to those observed with a mutation near the amino terminus of the beta-protein domain of beta-APP. This mutation resulted in a two-fold decrease of a potentially amyloidogenic 11 kDa peptide fragment. The data suggest that the FAD and HCHWA-D mutations have no effect on the formation of potentially amyloidogenic fragments in this cell system, possibly implicating an alternative mechanism for their effects.
据报道,β-淀粉样前体蛋白(β-APP)基因内的突变与早发性家族性阿尔茨海默病(FAD)以及荷兰型遗传性脑出血伴淀粉样变性(HCHWA-D)共分离。在稳定转染的细胞中检测了这些突变对β-APP蛋白非淀粉样生成和潜在淀粉样生成加工途径产物的影响。这些突变体的加工过程似乎与野生型相同。这些结果与在β-APP的β蛋白结构域氨基末端附近的一个突变所观察到的结果形成了鲜明对比。这个突变导致一个潜在的淀粉样生成的11 kDa肽片段减少了两倍。数据表明,FAD和HCHWA-D突变在这个细胞系统中对潜在淀粉样生成片段的形成没有影响,这可能暗示了它们发挥作用的另一种机制。